Pulse Biosciences (PLSE) EPS (Weighted Average and Diluted) (2021 - 2022)

Pulse Biosciences (PLSE) recorded quarterly EPS (Weighted Average and Diluted) of -$0.49 in Q3 2022, down 11.36% quarter-over-quarter from -$0.44 in Q2 2022, and down 2.08% on a YoY basis from -$0.5 in Q3 2021.

Pulse Biosciences (PLSE) EPS (Weighted Average and Diluted) (2021 - 2022) Analysis & Trends

Pulse Biosciences' EPS (Weighted Average and Diluted) history runs 2 years deep, the most recent figure standing at -$0.49 for Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 2.28
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -1.11
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 0.16
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 2.74
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 1.92
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 0.07
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -0.40
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 1.57
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -0.03
10 Pulse Biosciences 1.68 Bn 1.68 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 -0.49
Jun 30, 2022 -0.44
Sep 30, 2021 -0.48
Jun 30, 2021 -0.58